Status:
ENROLLING_BY_INVITATION
Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
18+ years
Brief Summary
The investigators will use machine learning to identify features on bone marrow smears and select features that are related to gene mutations, gene expression, or prognosis. The investigators will the...
Eligibility Criteria
Inclusion
- Diagnosed with acute myeloid leukemia at the National Taiwan University Hospital
- Ever enrolled in 201802021RINC、202109078RINB、201709072RINC
Exclusion
- Nil
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT05983172
Start Date
August 1 2023
End Date
July 1 2026
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100